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Monoclonal antibodies (mAbs) against secreted hemagglutinin (H) protein of rinderpest virus (RPV) expressed by a
recombinant baculovirus were generated to characterize the antigenic sites on H protein and regions of functional
significance. Three of the mAbs displayed hemagglutination inhibition activity and these mAbs were unable to neutralize virus
infectivity. Western immunoblot analysis of overlapping deletion mutants indicated that three mAbs recognize antigenic
regions at the extreme carboxy terminus (between amino acids 569 and 609) and the fourth mAb between amino acids 512
and 568. Using synthetic peptides, aa 569–577 and 575–583 were identified as the epitopes for E2G4 and D2F4, respectively.
The epitopic domains of A12A9 and E2B6 mAbs were mapped to regions encompassing aa 527–554 and 588–609. Two
epitopes spanning the extreme carboxy terminal region of aa 573 to 587 and 588 to 609 were shown to be immunodominant
employing a competitive ELISA with polyclonal sera form vaccinated cattle. The D2F4 mAb which recognizes a unique
epitope on RPV-H is not present on the closely related peste des petits ruminant virus HN protein and this mAb could serve
as a tool in the seromonitoring program after rinderpest vaccination. © 2002 Elsevier Science (USA)INTRODUCTION
Rinderpest virus (RPV) is an important member of the
morbillivirus genus in the Paramyxoviridae family. The
virus affects domestic cattle and buffaloes as well as
many cloven-hoofed animals in the wild and therefore
the disease is economically significant; the disease is
enzootic in south Asia and the Near and Middle East
(Barrett and Rossiter, 1999). RPV consists of two cell
surface glycoproteins—hemagglutinin H, which binds to
the cellular receptor to begin the process of infection,
and the fusion protein F, which helps in virus entry by
way of the fusion of the virus envelope with the host cell
membrane. These two proteins together are responsible
for protective immunity (Yilma et al., 1988; Romero et al.,
1994) and thus are considered promising candidates for
subunit vaccines.
The expression of a recombinant H protein of RPV in
secreted (Sec H) as well as membrane-bound forms
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214using baculo expression systems (Naik and Shaila, 1997)
facilitated the examination of the immunogenic proper-
ties of the recombinant baculovirus expressing the mem-
brane-bound H protein as extra cellular baculovirus par-
ticles (rECV-H) in cattle (Naik et al., 1997). Subsequently,
the H protein presented on rECV particles was shown to
generate virus neutralizing antibodies, helper T cell re-
sponses in cattle (Sinnathamby et al., 2001a).
We and others (Bhavani et al., 1989; Sugiyama et al.,
1989; Anderson and McKay, 1994) have earlier reported
the production and characterization of a panel of mAbs
to H protein. However, the linear and/or conformational
epitopes for these mAbs were not mapped on the pro-
tein, which could provide an insight into the antigenic
structure of the protein. Recently, neutralizing immuno-
dominant epitopes on RPV-H have been mapped using
selected mAb-resistant mutants of a lapinized strain
(Sugiyama et al., 2002). However, there is no information
concerning the major antigenic region(s) on the H pro-
tein, which carries epitopes unique to RPV-H and not
present on the corresponding protein of pestes des peti-
tis ruminant virus (PPRV), recognized by non-cross-reac-
tive monoclonal antibodies. In the present work, we
report the generation of mouse mAbs against RPV-H
using recombinant H produced in a secretory form in
insect cells as the immunizing antigen in mice. Of sev-
eral clones isolated, four have been extensively charac-
terized. B-cell epitopes recognized by these mAbs wereKey Words: rinderpest virus; hemagglutinin protein; mon
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mapped to the extreme carboxy terminus of H using
truncated proteins derived from overlapping gene dele-oclona
tion constructs of the H gene, expressed and purified
from Escherichia coli (Sinnathamby et al., 2001a) and a
panel of synthetic peptides representing the sequences
of H and closely related measles virus H protein.
RESULTS
Specificity and biological properties of mAbs
A secretory form of the hemagglutinin protein (mem-
brane anchorless) of RPV was employed to generate
hybridomas. The reactivity of mAbs was tested using
RPV (RBOK vaccine strain)-infected Vero cell extracts.
Thirty-nine parental clones secreting antibodies reactive
with H protein were chosen for subcloning by limiting
end point dilution. In order to obtain mAbs with different
specificities, one clone from each parental clones was
selected after subcloning. Finally, four subclones secret-
ing the mAbs in a stable manner were chosen (D2F4,
E2G4, E2B6, and A12A9) for the generation of ascitic
fluid. As PPRV-HN and RPV-H are antigenically closely
related, it was necessary to assess the cross-reactivity
of the mAbs with PPRV-HN and three clones (E2G4,
A12A9, and E2B6) cross-reacted with PPRV (Nig 75/1)-
infected cell extracts, while the fourth clone, D2F4, was
non-cross-reactive (Table 1). The immunoglobulin class
and subclass of the mAbs were defined using isotype-
specific ELISA and the results are summarized in Table 1.
The reactivity patterns of mAbs were also tested using
intracellular and cell surface immunofluorescence with
either RPV-infected Vero cells or PPRV-infected Vero
cells (Fig. 1). The cross-reactivities of three of the four
mAbs (data not shown) and the non-cross-reactivity of
D2F4 are shown in Fig. 1, which matched the ELISA
results. When tested for their ability to neutralize the
infectivity of RPV (RBOK) and PPRV (Nig 75/1) on Vero
cells, it was observed that none of the antibodies neu-
tralized virus infectivity (data not shown). Three of the
cross-reactive mAbs (E2G4, A12A9, and E2B6) inhibited
hemagglutination activity, while D2F4 did not, which in-
dicated that the determinants recognized by these two
groups of antibodies are different (Table 2).
Mapping of B-cell epitopes on the hemagglutinin
protein
The immunoreactivity pattern of D2F4 in Western blot
analysis using six different RPV-H deletion fragments
indicated that only two deletion mutants, namely, N448
and N511, were recognized (Fig. 2A and Table 2). Mabs
E2G4 and E2B6 in the Western blot analysis gave similar
immunoreactivity patterns (data not shown). A12A9 rec-
ognized three deletion mutants, namely, N448, N511,
and N359C41 (Fig. 2B and Table 2). From the immu-
noreactivity pattern in Western analysis employing dele-
tion mutants of RPV-H, it was deduced that the domain
recognized by three mAbs (D2F4, E2G4, and E2B6) lies in
the region comprising aa 569–609 (extreme 41 aa in the
carboxy terminus of H protein) and the domain recog-
nized by mAb A12A9 is aa 512–568. By employing a
recombinant fragment N241 of PPRV (AP94/1) hemag-
glutinin neuraminidase (HN), it was further confirmed that
E2G4, A12A9, and E2B6 cross-reacted with PPRV-HN and
D2F4 failed to recognize this protein (Fig. 3).
In order to further narrow down the mAb binding re-
gion, two 15-mer overlapping peptides (peptides 51 and
52, Partidos et al., 1991) specific for the highly homolo-
gous MV-H protein spanning the region aa 563–587 (with
a 5-aa overlap) were used. These MV peptides have
been shown to elicit helper T-cell response in mice
(Partidos et al., 1991). Comparison of the amino acid
sequences for MV-H and RPV-H in this region reveals
about 67% identity of peptides 51 and 52 and conserva-
tive substitutions making up the rest of the changes, thus
bringing a high degree of homology. The results of the
peptide ELISA performed with all four mAbs (Table 3)
indicated that E2G4 and D2F4 showed binding to aa
563–577 and 573–587, respectively. Subsequently, to nar-
row down the sites recognized by the mAbs to the pre-
cise epitope level, two 9-mer synthetic peptides for
TABLE 1
Properties of Rinderpest Virus Hemagglutinin Protein Monoclonal Antibodies
RPV-H mAbs Antibody class Light chain Cross-reactivity with PPRV
Immunofluorescence (IF)
(a) RPV (RBOK) (b) PPRV (Nig 75/1)
Intracellular Cell surface Intracellular Cell surface
D2F4 IgM      
E2G4 IgG2b      
E2B6 IgG2b      
A12A9 IgM      
Note. () Low reactivity in ELISA or IF; () moderate reactivity in ELISA or IF; () high reactivity in ELISA or IF; () negative reaction in ELISA
or IF.
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RPV-H protein in the region spanning aa 569–583 (with a
3-aa overlap) were used. The peptide ELISA results (Ta-
ble 3) successfully identified the epitopes for the mAbs
E2G4 and D2F4 to be aa 569–577 and 575–583, respec-
tively.
In order to localize the epitope for A12A9 mAb, two
each of non-overlapping 6-mer and 7-mer synthetic pep-
tides spanning the region aa 527–554 were tested for
their reactivities in peptide ELISA (results not shown).
The results showed that A12A9 mAb reacted with three
peptides spanning the region aa 527–554, indicating the
possibility of the coming together of the epitope associ-
ated with the structural form adopted by amino acids
527–554. Based on the reactivity of mAb E2B6 in Western
blot analysis and nonreactivity with any of the synthetic
peptides used, it is likely that E2B6 recognizes an
FIG. 1. Reactivity of RPV-H monoclonal antibody D2F4 by immunofluorescence staining of infected Vero cells. Vero cells grown on coverslips were
infected with (row A) rinderpest virus (RBOK) and (row B) peste des petits ruminants virus (Nig 75/1) at 48 h postinfection; only the coverslips intended
for intracellular fluorescence study were fixed (row A) and (row B) coverslips were reacted with D2F4. All the coverslips were reacted with antimouse
fluorescein isothiocyanate secondary antibody and finally examined using a fluorescence microscope. (Row C) Infected Vero cell. Original
magnification, 10 used for all the exposures.
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epitopic determinant in a stretch of 21 aa, between aa
588 and 609.
Identification of immunodominant epitopes
To determine if the epitopes recognized by the mAbs
are immunodominant, we carried out a competitive
ELISA in which sera from cattle vaccinated with tissue
culture rinderpest vaccine were used as competitors for
mAbs for binding to the corresponding epitopes, mapped
in the present work (Fig. 4). The ascites of all four mAbs
had titers of over 1500 in indirect ELISA using Sec H as
well as RPV-infected cell lysate. Binding of two mAbs to
their epitopes was inhibited by immune sera (Fig. 5),
suggesting that these epitope/epitopic regions are im-
munodominant (aa 573–587 and 588–609). The immuno-
dominant epitopic region as identified in the present
work also contains the neutralizing epitope of H (aa
587–592) identified recently (Sugiyama et al., 2002) on
the H protein of lapinized rinderpest virus.
DISCUSSION
We have earlier demonstrated that baculovirus-ex-
pressed membrane-bound RPV-H (Naik et al., 1997; Sin-
nathamby et al., 2001b) and PPRV-HN (Sinnathamby et
al., 2001c) generate virus neutralizing antibodies and
cell-mediated immune responses in the natural hosts
cattle and goats, respectively. Thus, baculovirus-ex-
pressed protective antigens of complex viruses can be
TABLE 2
Reactivity of RPV-H mAbs with Hemagglutinin Deletion Mutants of Hemagglutinin Protein in Western Blot Analysis
RPV-H protein
region (aa)
Name of the deletion
fragment
mAb
D2F4 E2G4 E2B6 A12A9
449–609 N448    
512–609 N511    
360–568 N359C41    
113–182; 425–450 N112;183-424;C160    
357–424 N356C185    
113–182 N112C427    
Note. () Signals with a specific deletion protein fragment; () negative with that specific deletion protein fragment. All the deletion fragments
reacted with polyclonal hyperimmune serum against rinderpest virus.
FIG. 2. Reactivity of RPV-H mAbs with RPV-H deletion proteins by Western immunoblot. Purified proteins (1 g) were electrophoresed on a 13.5%
SDS–polyacrylamide gel (A) and 12% (B); the blots were probed with mAbs at dilutions 1 in 5000 for D2F4 and 1 in 3000 for A12A9 asctic fluid. (A)
Lanes: 1, N359;C41; 2, N112;183-424;C160; 3, N448; 4, N511; 5, N112;C427; and 6, N356;C185. (B) Lanes: 1, N359;C41; 2, N448;
3, N511; 4, N112;183-424;C160; 5, N112;C427; and 6, N356;C185.
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employed in a wide variety of applications to strengthen
our knowledge of the immunological properties of such
antigens in isolation. Further, the recombinant H protein
was engineered for secretion into the medium by remov-
ing the membrane anchor region (Naik and Shaila, 1997).
This soluble form of H is similar to the membrane-bound
form, as shown by its reactivity with convalescent sera
from animals infected with RPV or sera from vaccinated
animals; therefore, this soluble recombinant H was used
to generate monoclonal antibodies with the objective of
identifying and characterizing a monoclonal antibody
unique to rinderpest virus for use in seromonitoring
work.
The immunoreactivity pattern of the three mAbs to
RPV-H deletions identified the antigenic domain to be aa
569–609 on RPV-H protein, while for the fourth one, it is
the aa 512–568 region. As the epitope recognized by the
mAb A12A9 spans a region of 57 aa, it is likely that the
epitope may have been formed by the conformation at-
tained by the amino acids in this region. Earlier work on
glycoprotein B of pseudorabies virus has shown that
continuous epitopic domains could be successfully iden-
tified in recombinant fragments (Zaripov et al., 1999).
Lack of authentic higher order structure of recombinant
proteins expressed in E. coli (Cason, 1994) can be ex-
ploited to identify linear epitopes on protein antigens.
Synthetic peptides have been successfully used to
identify B-cell epitopes (Ziegler et al., 1996). Hence we
used a panel of synthetic peptides to narrow down the
antigenic domains recognized by the mAbs. The reactiv-
FIG. 3. Western immunoblot reactivity of PPRV-HN deletion protein N241 with RPV-H mAbs. Purified PPRV deletion protein (1 g) was
electrophoresed on a 13.5% SDS–polyacrylamide gel (A and B) and 14.5% (C and D) and blotted onto nitrocellulose; the blot was then probed with
RPV-H mAbs (A) D2F4, (B) E2G4, (C) E2B6, and (D) A12A9 at appropriate dilutions.
TABLE 3
Reactivity of RPV-H mAbs with Synthetic Peptides
mAb designation
ELISA reactivity with MV-H peptides ELISA reactivity with RPV-H peptides
Peptide 51 Peptide 52 569ECFPWDRKL577 575RKLWCHHFC583
D2F4    
E2G4    
E2B6    
A12A9    
TCRV vaccinated serum (positive)    
Preimmune serum (negative)    
Note. Peptide 51, 563PIELOVECFTWDQKL577, and peptide 52, 573WDQKLWCRHFCVLAD587. All the peptides showed positive signals with rinderpest
hyperimmune serum.
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ity of the two mAbs E2G4 and D2F4 with two 15-mer
MV-H synthetic peptides (peptides 51 and 52) indicated
that closely related viral peptides can be made use of
while searching for epitopes. Finally, the precise B-cell
linear epitopes of E2G4 and D2F4 (aa 569–577 and
575–583) were successfully mapped based on their re-
activity with two 9-mer RPV-H peptides and similarly,
based on the reactivity of mAb A12A9 with two 6-mer and
one 7-mer RPV-H peptides, the epitopic domain of A12A9
mAb was identified to be aa 527–554 (28 aa). Based on
its reactivity in Western blot and nonreactivity with any of
the synthetic peptides used in this study, the binding
region of the fourth mAb, E2B6, was localized to a 21-aa
stretch (between aa 588 and 609); hence, the epitopes of
the two mAbs A12A9 and E2B6 may constitute a linear or
even a conformation-dependent epitope.
Two major T-helper (Th) epitopes on RPV-H in cattle
have been identified (Sinnathamby et al., 2001a). One of
the epitopes was identified at the extreme carboxy ter-
minus (aa 575–583). This region overlaps the B-cell
epitopic region (aa 569–583) identified in this work. This
is the first demonstration of the occurrence of overlap-
ping B-cell and Th epitopes on the H protein.
In a recent study, a number of mAbs against epitopes
587 to 592 on RPV-H were identified compared to those
against other epitopes (Sugiyama et al., 2002); the immu-
nodominant epitopes recognized by two of the mAbs in the
present work (D2F4 and E2B6) fall in the same region as
epitopes D and E reported by these authors. Our finding
also demonstrates that all the four mAbs are from the
extreme carboxy terminal domain and the region encom-
passing the epitopes for two mAbs is beyond aa 575 (Fig.
4). The two mAbs which recognize the immunodominant
epitope/epitopic domain are nonneutralizing, which sug-
gests that all the immunodominant B-cell epitope/epitopic
domain need not elicit neutralizing antibody. The character-
ization of the linear non-cross-reactive epitope recognized
by the mAb D2F4 has provided a valuable tool for the
development of a highly specific C-ELISA kit for seromoni-
toring as well as for serosurveillance for rinderpest virus
infection (Renukaradhya et al., to be published).
PPRV has been shown to possess hemagglutination
activity, whereas RPV is devoid of this activity, although
antibodies to RPV-H inhibit the hemagglutination by
PPRV (Ramachandran et al., 1995). Therefore, the hem-
agglutination inhibition (HI) activity of RPV-H mAbs was
assessed. Three of the four RPV-H mAbs, E2G4, A12A9,
and E2B6, showed HI activity, with titers of 200–400,
while the fourth mAb, D2F4, did not show any HI activity,
FIG. 4. Locations of the immunodominant B-cell epitope/epitopic
domain of RPV-H in a schematic illustration, identified using RPV-H
mAbs. (A) Amino acids 527–554 to A12A9; (B) aa 569–577 to E2G4; (C)
aa 575–583 to D2F4; (D) aa 588–609 to E2B6. The full-length RPV-H
protein comprises 609 amino acids and each box represents one
epitope/epitopic domain.
FIG. 5. Identification of the immunodominant B-cell epitope/epitopic domain on RPV-H protein using mAbs A12A9, E2G4, D2F4, and E2B6 as tested
by C-ELISA using vaccinated cattle sera as competing antibodies. The percentage of inhibition (PI) value is calculated by the formula P I  100 (OD
in test well/OD in 0% control well)  100. A P I more than 34 was considered positive for the presence of the RPV-H antibodies. Each bar represents
average P I values of 10 sera.
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as it is non-cross-reactive with PPRV-HN (Table 1).
Monoclonal antibodies can also be grouped based on
their reactivity in various functional assays, such as virus
neutralization, HI, and hemolysis inhibition (HLI) activity
(Rydbeck et al., 1986). Four RPV-H mAbs can be classi-
fied into two groups based on their functional inhibitory
activities: group I, which showed HI activity, but did not
have both virus neutralization and HLI activities (three
non-cross-reactive mAbs, E2G4, A12A9, and E2B6), and
group II, which did not show HI activity, virus neutraliza-
tion, and HLI activities (RPV-H-specific and PPRV-HN
non-cross-reactive mAb, D2F4). Since the epitopes for
the HI mAb D2F4 (aa 575–583) overlaps one of the HI
mAb E2G4 (aa 569–577), one or more aa in the 569–577
region seems to be a major determinant for the hemag-
glutination or cell attachment function of the H protein.
This is in close proximity with residue 546 on MV-H
protein involved in HA activity (Hummel and Bellini,
1995).
RPV and PPRV are two distinct, but antigenically
closely related viruses, which are the causative agents of
RP and PPR. PPRV also causes subclinical infection in
large ruminants, which in turn serves as a carrier of
infection to sheep and goats, apart from protecting the
bovine population against RPV infection (Dardiri et al.,
1977). This posed a problem earlier in differentiating
them serologically; it is very essential to differentiate
these two diseases serologically to achieve a successful
RP serosurveillance program. Similarly, to assess vac-
cine efficacy, it is essential to carry out seromonitoring
using rinderpest-specific C-ELISA. In order to differenti-
ate the antibodies made against RPV from those against
PPRV during serosurveillance and seromonitoring stud-
ies, it is important to use a highly specific monoclonal
antibody which recognizes a unique epitope on the RPV
antigen. The generation of such a mAb recognizing a
unique epitope on RPV-H protein as shown in this work
could serve such a role.
MATERIALS AND METHODS
Cells and viruses
Vero cells were cultured in Dulbecco’s modified Ea-
gle’s medium (DMEM, Himedia, India) supplemented
with 5% fetal calf serum (FCS, Gibco-BRL, U.S.A.). Spo-
doptera frugiperda (Sf)-21 cells were grown in TC-100
insect cell culture medium (Gibco BRL, U.S.A.) supple-
mented with 10% fetal bovine serum (FBS, Gibco BRL).
Hybridoma cells were cultured in Iscove’s modified Dul-
becco’s medium (IMDM, Gibco BRL) supplemented with
10% FBS. Baculo recombinant viruses expressing solu-
ble, Sec H and the membrane-bound form have been
described earlier (Naik and Shaila, 1997) and were prop-
agated in Sf-21 cells. PPRV Nig 75/1 was obtained from
Dr. A. Diallo, CIRAD-EMVT, France, and RPV (RBOK vac-
cine strain) was obtained from the Institute of Animal
Health and Veterinary Biologicals, Bangalore. They were
propagated on Vero cells. Parental clones of hybridoma
were selected using HAT medium (hypoxanthine, ami-
nopterin, and thymidine, Gibco BRL) and HT medium
(hypoxanthine and thymidine, Gibco BRL).
Titration of recombinant baculovirus by TCID50 assay
Sf-21 cells were plated on flat-bottomed 96-well tissue
culture plates (Costar, U.S.A.) at a density of 1  105
cells/ml; 10-fold dilutions of the virus was performed in
complete TC-100 medium. Virus dilutions (100 l) were
then added in replicate wells and incubated at 27°C for
4 days and the development of cytopathic effect (CPE)
was recorded. TCID50 was calculated employing the
Reed and Muench formula (Burleson et al., 1992).
Expression and purification of deletion mutants of
RPV-H protein
Construction of deletion mutants of RPV-H and PPRV-
HN protein, expression as His-tagged fusions in E. coli
strain BL21(DE3), purification, and also stably expressed
deletion mutants were confirmed by Western blot,
probed with rabbit hyperimmune serum to RPV (RBOK)
as described earlier (Sinnathamby et al., 2001a). The
deletion mutants of PPRV-HN, N241 and RPV-H N448,
N511, N359;C41, N112;183-424;C160, N356;
C185, and N112;C427 were employed in this study,
where N112;183-424;C160 is a deletion mutant that
does not express the N-terminal 112 aa, the C-terminal
160 aa, an internal stretch between aa 183 and 424, and
so on.
Western blot analysis of the recombinant proteins
Equal amounts of deletion proteins were electro-
phoresed on SDS–polyacrylamide gels and proteins
were transferred onto nitrocellulose membrane (Amer-
sham, UK) using a semidry transfer apparatus (LKB,
U.S.A.). The blot was then blocked with blocking buffer
(3% gelatin in PBS) for 1 h at room temperature and then
incubated with appropriately diluted mAbs in blocking
buffer. After incubation for 1 h at room temperature,
horseradish peroxidase (HRP)-conjugated antimouse an-
tibody (Boehringer Manheim, Germany) in blocking
buffer was added and the blot was incubated for 1 h at
room temperature. Then the blot was developed using
hydrogen peroxide and diaminobenzidine (DAB) (Sigma
Chemicals Co. St. Louis, MO) in PBS. The membrane
washed after each incubation step three times using
PBS containing 0.1% Tween 20 (Merck, Germany) (PBST).
Synthetic peptides
MV-H peptides were a kind gift from Dr. M. Steward,
London School of Hygiene and Tropical Medicine, United
Kingdom. Sequences of MV-H peptides that were
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employed in this study correspond to peptide 51,
PIELOVECFTWDQKL (positions 563–577), and peptide
52, WDQKLWCRHFCVLAD (positions 573–587). Two
9-mer synthetic overlapping peptides were synthesized
corresponding to the region aa 569–577 (peptide 1, ECF-
PWDRKL) and aa 575–583 (peptide 2, RKLWCHHFC) on
RPV-H protein. Four non-overlapping peptides corre-
sponding to different specified locations on the H protein
of RPV, peptide 1, ATYDISR (aa 527–533); peptide 2,
SSYYYP (aa 549–554); peptide 3, FHMTNYL (aa 270–
276); and peptide 4, EHAIVY (aa 535–540), were also
used for reactivities in peptide ELISA with H mAbs.
Competitive ELISA
C-ELISA was performed essentially as described pre-
viously (Anderson and McKay, 1994). Briefly, the baculo
recombinant Sec H of RPV prepared in serum-free me-
dium was used as an antigen for C-ELISA. Each well of
a 96-well microtiter plate was coated with the antigen (5
g/ml) at 4°C overnight and treated with blocking buffer
[PBS supplemented with 0.1% (v/v) Tween 20 and 0.3%
(v/v) normal bovine serum seronegative for RPV] for 1 h
at 37°C. After washing five times in phosphate-buffered
saline (0.2 PBS), appropriate dilutions of test sera (10
negative and 50 positive sera) and anti-H mAbs (D2F4,
E2B6, A12A9, and E2G4) were added. Controls were
included, such as strong positive, weak positive, and
negative bovine sera and a mAb (0% competition) con-
trol. Monoclonal antibody control wells (0% competition)
contained antigen, mAb, and enzyme conjugate (no test
serum). Following incubation at 37°C for 1 h in an orbital
shaker, plates were washed and antimouse HRPO con-
jugate (predetermined dilution) was added. After a final
incubation, substrate/chromogen (OPD/H2O2) was added
and the color allowed to develop for 10–15 min. Plates
were read on a ELISA reader at 490 nm and analyzed
using enzyme immunoassay (EIA) software (Biologicals
Diagnostic Supplies Ltd., United Kingdom) and the OD
values were converted to percentage of inhibition (P I)
values using the following formula. P I  100 (OD in test
well/OD in 0% control well)  100.
Purification of recombinant Sec H protein
Sf-21 cells were adapted gradually to serum-free me-
dium (Sf-900 II SFM, Gibco-BRL). Then the cells were
infected with the recombinant baculovirus expressing H
in a secretory form (Naik and Shaila, 1997) at an m.o.i. of
10. The culture supernatant was collected after 72 h
when more than 90% CPE was observed, and the super-
natant was clarified by centrifugation at 4000 g for 30
min. The supernatant was precipitated with ammonium
sulfate at 60% saturation. The precipitate was dialyzed
against column binding buffer (Tris–HCl, pH 7.8, 10 ml, 50
mM NaCl, 1% Triton X-100, and 1 mM PMSF) and purified
on a rabbit anti-RPV-H antibody affinity column as de-
scribed by Naik et al. (1997). Briefly, immunoglobulins
from 2 ml of monospecific polyclonal rabbit antiserum
were precipitated at 50% ammonium sulfate saturation
and the dialyzed immunoglobulins were coupled to
CNBr-activated Sepharose 4B, blocked with ethanol-
amine, and used to make the affinity column. This col-
umn was equilibrated with 20 vol of wash buffer (the
same as binding buffer). After recycling the supernatant
(a dialysate of Sec H) thrice at a flow rate of about 10
ml/hour, the column was washed with 20–25 ml of wash
buffer at a flow rate of 12 ml/hour at 4°C. The column-
bound protein was eluted with elution buffer (0.2 M
glycine, pH 2.8, and 0.2% Triton X-100) and the eluate
was immediately neutralized with 1 M Tris solution. Ten
fractions of 1 ml each were eluted, pooled, and lyophi-
lized until further use. The purified protein was used for
immunization in BALB/c mice.
Generation of RPV-H hybridoma clones
BALB/c mice were immunized subcutaneously (sc)
with 100 g of purified Sec H protein in Freund’s com-
plete adjuvant and they were boosted twice with 50 g of
Sec H in Freund’s incomplete adjuvant at 3-week inter-
vals. A week following the second booster injection,
mice were bled and H-specific ELISA titers were deter-
mined. A titer of 1:100,000 was considered optimum for
carrying the fusion. Three weeks after the second
booster, mice were further boosted with 100 g of puri-
fied Sec H intraperitonealy. Four days later, one of the
immunized animal was sacrificed to make a spleen cell
suspension which was fused with Sp2/0 myeloma cells
by standard PEG-mediated fusion as described by Bha-
vani et al. (1989).
Parental clones were subjected to sub-cloning to
achieve monoclonality of the clones. One clone from
each parental clone was selected based on its reactivity
with Sec H and RPV-RBOK infected cell extract in ELISA.
These hybridomas (1 106 cells per ml) were injected in
PBS intra-peritonealy into pristine primed Balb/c mice for
ascites production and after 10 to 14 days ascitic fluid
was collected. The antibody titer in the ascitic fluid was
determined using Sec H or infected cell extracts of RPV
(RBOK) as coating antigen in indirect ELISA.
RPV (RBOK)- and PPRV (Nig 75/1)-infected cell
extracts
RPV (RBOK) and PPRV (Nig 75/1) viruses were propa-
gated in Vero cells. At 60–70% confluency, Vero cells
were infected at an moi 10. After 48–72 hrs when 60–70%
cpe was visible, infected cells were scraped and were
gently washed once with PBS and then resuspended in
PBS. The cell suspension (1  1010 cells ml1) was
sonicated in a Vibracell (U.S.A.) ultrasonic processor and
clarified at 10,000 g for 10 min. Protein concentration
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was estimated by Lowry method (1972) and used in
indirect ELISA.
Indirect ELISA
ELISA plates were coated with lysates of Vero cells
infected with PPRV Nig 75/1 and RPV-RBOK strain at a
concentration of 1 g/well or culture supernatants con-
taining Sec H (500 ng/well) for 1 h at 37°C or overnight at
4°C. The plate was washed in PBS thrice and blocked
with blocking buffer (3% bovine gelatin  0.1% Tween 20
in PBS) for 1 h at 37°C. Serial dilutions of the RPV-H-
specific mouse hyperimmune serum/hybridoma culture
supernatant/ascitic fluid in PBS were used as primary
antibody and incubated at 37°C for 1 h. The plates were
then washed and appropriately diluted antimouse whole
Ig-HRP or antimouse IgM-HRP conjugate was added and
the plates were incubated at 37°C for 1 h. The reaction
was developed using O-phenylenediamine dihydrochlo-
ride and H2O2 and the reaction was stopped with 2 N
H2SO4. The plates were read at 490 nm in an ELISA
reader.
Supernatants collected from each hybridoma clone
were subjected to an isotyping ELISA using the Boeh-
ringer Mannheim isotyping kit according to the manufac-
turer’s instructions.
Peptide ELISA
ELISA plates were coated overnight at 4°C with the
peptides at a concentration of 25 ng per well using
carbonate bicarbonate buffer (pH 9.6  0.05) and
blocked with blocking buffer (3% bovine gelatin  0.1%
Tween 20 in PBS) for 1 h at 37°C. Appropriate dilutions of
the ascites (both RPV-H mAbs) in blocking buffer were
added and incubated at 37°C for 1 h, followed by addi-
tion of appropriately diluted secondary antibody (anti-
mouse whole Ig-HRP conjugate) incubated at 37°C for
1 h. Between each step, plates were washed three times
with wash buffer (0.1% Tween 20 in PBS). As a positive
control, serum from cattle vaccinated with TCRV was
used and for a negative control, preimmune serum of the
same animal was used. For control sera appropriately
diluted secondary antibody (antibovine whole Ig-HRP
conjugate) was used. The plates were developed with
O-phenylenediamine dihydrochloride and H2O2 as sub-
strate chromogen and read at OD 490 nm in an ELISA
reader.
Immunofluorescence
Vero cells grown on coverslips were infected with RPV
(RBOK) and PPRV (Nig 75/1) at a m.o.i. of 10 and when
the cells showed 30–40% CPE, coverslips were washed
gently in PBS. Acetone-fixed cells (intracytoplasmic de-
tection) or unfixed cells were used for immunofluores-
cence as described by Harlow and Lane (1988).
Hemagglutination and hemagglutination inhibition
assays
Hemagglutination assay was performed according to
Rosanff (1961). For HI assay, ascitic fluids were double
diluted in PBS in a volume of 25 l starting with an initial
dilution of 1 in 5 in a round-bottom 96-well plate; 25 l of
4 HA units of PPRV antigen (PPRV-Nig-75/1-infected cell
extract) was added to the wells. Then the standard HI
procedure was followed (Norrby, 1962).
Virus neutralization assay
RPV-H mAbs were tested for their ability to neutralize
RPV (RBOK) and PPRV (Nig 75/1) infectivity in vitro on
Vero cells according to the method of Barrett et al. (1989).
Development of CPE was monitored by light microscopy
and the titers were expressed as the reciprocal of the
highest dilution of ascites, which neutralized 50% of virus
infectivity.
Hemolysis (HL) and HLI
Both HL and HLI assays were performed according to
the method of Norrby and Gollmar (1975).
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